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Isolated hematuria in children: Indications for a renal biopsy. Previous
reviews of hematuria in children and adolescents have included patients
with proteinuria and other renal functional abnormalities such as
hypertension and reduced GFR. We report the clinico-pathological
correlations in 76 pediatric patients, aged 3 to 19 years, who underwent
a renal biopsy because of isolated hematuria during the 10-year period,
1972 to 1981. All specimens were examined by light and electron
microscopy and immunofluorescence techniques. The overall preva-
lence of abnormal renal histology was 56%. The vast majority (41 of 43)
of the abnormal biopsy specimens could be classified into four distinct
histological categories: (1) Alport syndrome (N = 9); (2) IgA nephrop-
athy (N = 8); (3) thinning of the glomerular basement membrane (N =
17); (4) vascular C3 staining (N = 7). The children were divided into
three clinical subgroups (1) isolated microscopic hematuria (IMH), N =
42; (2) IMH plus a family history of hematuria in a first degree relative,
N = 15; and (3) IMH plus at least one episode of gross hematuria, N =
19. A significant graded increase in the likelihood of obtaining an
abnormal renal biopsy was demonstrated (X2 = 10, P < 0.007) from
groups one to three. Sex, age at onset, or duration of hematuria were
not associated with an increased proportion of histopathologic abnor-
malities. These findings indicate that the yield of a renal biopsy in
children with isolated hematuria can be predicted accurately from
specific clinical characteristics.
Hematurie isolee de l'enfant: Indication de Ia biopsie renale. Des
revues anterieures sur les hématuries de les enfants et de les adoles-
cents incluaient les malades ayant une protCinurie et d'autres anomalies
fonctionnelles rénales comme une hypertension et une diminution de
GFR. Nous rapportons des correlations clinico-pathologiques chez 76
malades pédiatriques, ages de 3 a 19 ans, qui ont subi une biopsie rdnale
en raison d'une hématurie pendant une période de 10 ans, 1972 h 1981.
Tous les échantillons ont été examines en microscopie optique et
electronique, et avec des techniques d'immunofluorescence. La preva-
lence globale d'une histologie rénale anormale était de 56%. La grande
majorité (41 du 43) des échantillons biopsies anormales pouvait être
classée en quatre categories histologiquement distinctes: (1) Syndrome
d'Alport (N = 9); (2) néphropathie a IgA (N = 8); (3) amincissement de
Ia membrane basale glomerulaire (N 17); et (4) coloration vasculaire
avec C3 (N = 7). Les enfants ont été divisés en trois sous-groupes
cliniques: (1) hématurie microscopique isolée (IMH), N = 42; (2) IMH
plus une histoire familiale d'hématurie chez un parent du premier degre,
N = 15; (3) IMH plus au moms un episode d'hématurie macroscopique,N = 19. Une augmentation progressive significative de Ia possibilité
d'obtenir une biopsie rénale anormale a ete démontrée (X2 = 10, P <
0,007) des groupes un a trois. Le sexe, l'âge lors de La découverte, ou Ia
durée de l'hématurie n'étaient pas associés a une proportion augmentée
d'anomalies histopathologiques. Ces données indiquent que le résultat
d'une biopsie rénale chez des enfants avec une hématurie isolée peut
être predit de facon precise a partir de caractéristiques cliniques
specifiques.
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The point prevalence of asymptomatic hematuria in the
pediatric population ranges from 0.5 to 2.0% according to
recent screening surveys of school age children [1, 2]. Despite
the frequency of its detection, considerable disagreement per-
sists about the proper nature and extent of the diagnostic work-
up that is warranted for this solitary urinary abnormality [3]. In
particular, the role of a renal biopsy in the evaluation of the
child with hematuria remains controversial. Previous reviews of
children with hematuria failed to correlate renal biopsy findings
with the presence or absence of gross hematuria, positive
family histories of hematuria, or concomitant proteinuria [2, 4—
9].
The present retrospective review of children with isolated
hematuria who underwent renal biopsy at a referral center was
undertaken to provide the following information: (1) the overall
prevalence of abnormal renal histology among these patients;
(2) the identification of those clinical characteristics that may
enable recognition of children with an increased likelihood of
having abnormal renal histology; (3) a description of two
histologic patterns observed in children with hematuria, thin-
ning of the glomerular basement membrane (GBM) and vascu-
lar C3 staining, that have not been associated with a clinically
defined nosological entity; and (4) assessment of the clinical
course of children with isolated microscopic hematuria.
Methods
The clinical records and pathology reports of all children with
hematuria who underwent a renal biopsy at the Hospital of the
Albert Einstein College of Medicine, Bronx, New York, in the
years 1972 to 1981 were reviewed. During this period, the
prevailing practice was to perform a renal biopsy in any child
with hematuria lasting longer than 6 months. Patients were
included in the study only if an adequate tissue specimen was
available for examination by light and electron microscopy and
immunofluorescence techniques. The children were well except
for the finding of hematuria and had no signs or symptoms
suggestive of a systemic disease. They had no clinical or
radiographic signs of nephrolithiasis at the time of renal biopsy.
Routine prebiopsy laboratory evaluation included a urine cul-
ture, serum creatinine concentration with an estimated GFR
[10], sickle cell screening, measurement of serum C3 concentra-
tion (radial immunodiffusion, Calbiochem-Behring Corp., La
Jolla, California), and an intravenous pyelogram at the time of
the biopsy. Assessment of urinary calcium excretion and audio-
grams were not routinely performed. The initial detection of
microscopic hematuria by a semiquantitative testing method
Fig. 1. Electron micrograph showing thinning
of the GBM. The capillary loop on the right side
of the figure is affected while those on the left
are of normal thickness. (x5400)
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(for example, Hemastix, Ames) was always confirmed by the
Addis count technique. Hematuria was defined as a RBC
excretory rate exceeding 240,000 per 12 hr in an overnight urine
collection on at least two occasions over a 6-month period. In
fact, every child who underwent a renal biopsy had at least one
Addis count demonstrating more than 500,000 RBC in a 12-hr
collection period. No distinction was made between patients
who had persistent abnormal urine testing results and those
who demonstrated only intermittent hematuria. Gross hematu-
na was defined by history or visual inspection of a urine
specimen. The family history for hematuria was considered
positive only if it involved a first degree relative (parent or
sibling). The documentation of a positive family history was
confirmed in one half of the cases by quantitative urine testing
of affected family members.
Proteinuria, defined in accordance with the International
Study of Kidney Diseases in Children as greater than 4
mgIM2/hr [11], was a criterion for exclusion from the study
group. An estimated GFR below 80 ml/min/l.73 M2, a blood
pressure exceeding the 95th percentile for age and sex [121, a
serum C3 level below 50 mg/dl, or an anatomic abnormality of
the urinary tract also served to exclude the affected patient from
further consideration in this review.
The renal biopsies were performed percutaneously under
fluoroscopic or ultrasound guidance. Following fixation in
solution (Dubosq-Brazil), paraffin sections were cut at 4-MM
thickness and stained with hematoxylin-eosin, Masson tn-
chrome, periodic acid Schiff and Jones' silver methenamine
methods. Frozen sections were cut and stained with fluorescein
isothiocyanate-coupled antisera to IgG, IgA, 1gM, C3, C4, and
fibrinogen. The tissue samples for electron microscopy were
fixed in glutaraldehyde, postfixed in osmium tetroxide and
embedded in Epon 812. Ultrathin sections were cut and stained
with uranyl acetate and lead citrate. The renal biopsy speci-
mens were interpreted by a single pathologist who was aware of
the clinical status of each patient.
IgA nephropathy (Berger disease) was defined as bright
staining with anti-IgA antisera in glomerular mesangia. Alport
syndrome was diagnosed on the basis of characteristic electron
microscopic abnormalities of the GBM, namely splitting and
lamination of the lamina densa with accumulation of small
dense particles in lucent areas between split layers [13—16]. The
thickness of the GBM was measured from the outer aspect of
the endothelial cell to the inner aspect of the visceral epithelial
cell, using a calibrated electron microscope. The accuracy of
the calibration was verified by comparison with a standard
reference grid photographed at equal magnification (x 20,000).
The measurements were made at a site along the peripheral
glomerular capillary loop where both cell membranes could be
resolved to insure that the determinations were uniform and
represented ideal cross sections. The width of the lamina densa
was also recorded. Measurements to establish the diagnosis of
GBM thinning were made only on those biopsy specimens in
which the thickness of a capillary loop appeared attenuated
along its entire extent. Thinning of the GBM was defined as an
endothelial-to-epithelial thickness less than 1500 A and a lamina
densa width less than 1,000 A at any location along its length
(Fig. 1). The presence of vascular C3 was defined by bright
staining of arterioles in the renal interstitium with anti-comple-
ment antisera (Fig. 2).
Followup information on the children with isolated micro-
scopic hematuria, Alport syndrome, and IgA nephropathy
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Table 1. Isolated hematuria
Clinical categories N %
Isolated microscopic hematuria (IMH) 42 55
Isolated microscopic hematuria plus a family
history of hematuria (IMH and F) 15 20
Microscopic hematuria plus at least a single
episode of gross hematuria (IMH and GH) 19 25
Total 76 /00
Four patients in this category also had a positive family history.
Table 2. Isolated hematuria
Fig. 2. Immunofluorescence photomicrograph showing the presence
of vascular C3. The arterioles in the interstitium contain granular
deposits. (x240)
consisted of the results of the most recent measurement of the
child's BP, urinalysis, and tests of renal function.
The results were analyzed utilizing the x2 test or, where
appropriate, Fisher's exact test. The student's t test was used to
compare the difference between the means of unpaired samples.
The results were considered statistically significant if P < 0.05.
Results
Biopsy specimens were taken from a total of 76 children with
isolated hematuria during the 10-year period (1972 to 1981).
Their ages were uniformly distributed between 3 and 19 years
with an equal number of male and female patients. Eight
adolescents were older than 15 years at the time of biopsy;
however, in seven instances the hematuria was detected prior
to 15 years of age. The duration of hematuria from the time of
detection to the date of biopsy ranged from 6 months to 14 years
with a mean interval of 32.4 months. Each biopsy specimen
contained at least 15 glomeruli. The only complication of the
procedure was a single instance of an AV fistula that required
embolization.
The children were divided into the following three clinical
categories based on historical data obtained prior to the biopsy
(Table 1): (1) isolated microscopic hematuria (IMH), N =42; (2)
isolated microscopic hematuria plus a family history of hematu-
na in a first degree relative (IMH and F), N = 15; and (3)
microscopic hematuria and episodes of gross hematuria (IMH
and GH), N = 19. Seven patients in this third group had only a
single episode while 12 patients had recurrent episodes of
macroscopic hematuria. The second and third categories were
not mutually exclusive; in fact, among the 19 children with GH
were four patients who also had a family history of hematuria.
The pathologic diagnoses made in the study population are
listed in Table 2. Thirty-three biopsy specimens (44%) were
considered completely normal after examination by light and
electron microscopy and immunofluorescence. Among the 43
children with abnormal renal histology, GBM characteristics of
Alport syndrome were detected in nine biopsy specimens (12%
of total sample), IgA nephropathy (Berger disease) in eight
(11%), and seven children (9%) had moderate to marked
immunofluorescence staining of arterioles in the interstitium for
Renal biopsy results N
% Total
biopsies
% Abnormal
biopsies
Normal 33 44 —
Alport syndrome 9 12 21
IgA nephropathy 8 II 19
Thinning of the GBM 17 22 40
Vascular C3 staining 7 9 16
Focal glomerulonephritis I I 2
Tubulointerstitial
nephritis I I 2
Total 76 100 /00
C3. In addition, there were 17 children (22%) with thinning of
the GBM. The total GBM and lamina densa widths in these
children were 1233 51 A (mean SE) and 682 31 A,
respectively. Both measurements were significantly less (P <
0.00001) than the values obtained in children with a normal
GBM, namely, 1863 31 A and 1402 40 A. Finally, two
biopsy specimens were abnormal but could not be placed into
these diagnostic categories; one revealed a mild focal glomeru-
lonephritis with increased mesangial matrix and hypercellular-
ity, the other an area of tubulo-interstitial nephritis.
Analysis of the data revealed that sex, age at detection of the
hematuria, and duration of the abnormality were not associated
with an increased likelihood of abnormal histology. However,
when the children were divided into the three clinical categories
defined above, there was a highly significant graded increase in
the proportion of abnormal biopsy results among children with
either a family history of hematuria (64%) or the occurrence of
gross hematuria (79%) compared to children with IMH (40%)
(X2 = 10, P < 0.007) (Table 3). The groups with a positive
family history of hematuria or any episodes of gross hematuria
had a higher incidence of Alport syndrome (P < 0.01) and IgA
nephropathy (P < 0.002). However, the distribution of thinning
of the GBM and vascular C3 staining among the three clinical
categories did not differ from that of the population of children
with hematuria as a whole (Table 4). Of the four children who
demonstrated both a positive family history of hematuria and at
least a single episode of gross hematuria, three had GBM
findings of Alport syndrome and one had IgA nephropathy.
Among the 40 patients with IMH whose renal biopsy speci-
men was either entirely normal (N = 25), demonstrated thinning
of the GBM (N = 10), or vascular C3 staining (N = 5), followup
data were available for 26 (65%) children. The duration of
followup dating from the detection of hematuria ranged from 13
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Normal 25 60 4 36 4 21 33 44
Abnormal 17 40 11 64 15 79 43 56
Total 42 100 15 100 19 100 76 100
Table 4. Isolated hematuria: Abnormal renal biopsy results by clinical
categories
IMH IMH and F
IMH and
GH
N % N % N %
Alport syndrome
IgA nephropathy
Thinning GBM
Vascular C3
FGN
Tubulointerstitial
nephritis
1
1
10
5
0
0
6
6
59
29
0
0
2
0
5
2
1
1
18
0
46
18
9
9
6 40
7 47
2 13
0 0
0 0
0 0
Total 17 100 11 100 15 100
to 90 months with a mean interval of 42.1 months. Twenty-two
(85%) of the children still had IMH, but none had manifested
any episodes of gross hematuria. All of the patients had yearly
evaluations that included measurement of BP, urinary protein
excretion, and serum creatinine concentration. No abnormali-
ties were detected in any of these three variables during the
followup period. Followup information was available for six of
the nine children with Alport syndrome, the mean interval being
60 months. Hematuria persisted in all six patients. Although
four of six patients had developed significant proteinuria, none
manifested any evidence of diminished renal function. Among
the eight children with IgA nephropathy, followup data was
obtained in six instances for a mean duration of 72 months. All
patients continued to have microscopic hematuria with inter-
mittent episodes of gross hematuria. However, no child has
developed proteinuria or signs of decreased renal function.
Discussion
The indications for performing a renal biopsy and the yield
and type of abnormal results that can be expected in a child with
isolated hematuria cannot be ascertained from the literature.
Previous clinico-pathologic correlations in children with hema-
tuna have included patients with proteinuria, hypertension, or
an abnormal GFR. Moreover, many of the older series were
compiled at a time when immunofluorescence and electron
microscopy were not standard procedures. We avoided these
confounding variables by examining the renal histopathology in
a large group of otherwise well children with isolated hematu-
na. All biopsy specimens were examined by light and electron
microscopy and immunofluorescence techniques. Analysis of
this homogenous sample of patients has enabled us to identify
clinical features associated with an increased likelihood of
abnormal renal histology, and thus formulate indications for
Total performing a renal biopsy in children with hematuria.
N Four histological lesions, Alport syndrome, IgA nephrop-
athy, thinning of the GBM and vascular C3 staining, accounted
for 95% of the abnormal renal biopsy specimens. IgA nephrop-
athy and Alport syndrome are established clinical entities and
are well recognized causes of isolated hematuria. IgA nephrop-
athy may present as IMH, but it is usually characterized by
recurrent, brief, and self-limited episodes of gross hematuria
occurring in association with upper respiratory infections [17,
18]. Although the prognosis for children with IgA nephropathy
is generally deemed to be favorable [17], pediatric patients have
been described who developed progressive glomerular sclerosis
and renal insufficiency [18—21]. Alport syndrome is the most
common variety of hereditary nephritis. It is characterized by a
positive family history of renal disease, sensorineural deafness,
ocular abnormalities, and progressive renal failure although all
four features need not be present to make a diagnosis [22].
Isolated hematunia in early childhood is often the first sign of
disease, with the subsequent appearance of proteinuria in later
years. Hearing loss may not develop until the second decade of
life. Progressive deterioration in renal function is more common
in males, although the interval until endstage renal disease
supervenes varies from family to family [16, 22]. In contrast to
Alport syndrome and IgA nephropathy, thinning of the GBM
[23—25] and vascular C3 staining are primarily histopathologic
diagnoses. At present, they have no distinctive clinical presen-
tation, course, or prognosis.
Thus, from the long list of glomerulopathies that are com-
monly enumerated in the differential diagnosis of hematunia, in
our series of children and adolescents with this isolated urinary
abnormality, we found that only two clinical entities occurred
with any significant frequency. The early diagnosis of Alport
syndrome is of value to provide genetic counseling to affected
families. However, the exact mode of inheritance of the syn-
drome is still controversial and may vary from kindred to
kindred [22]. In addition, no therapy presently available can
effectively halt the progression to renal failure. Knowledge that
a patient has IgA nephropathy is helpful in explaining the cause
of and alleviating the anxiety provoked by recurrent episodes of
gross hematuria. However, as with Alport syndrome, no form
of therapy is currently available that can shorten or modify the
natural history of this disease syndrome [17, 181.
The thinning of the GBM that we observed has been de-
scribed previously in children and adults [23—26]. Our diagnos-
tic criteria for this lesion were considerably more strict that
those of previous reports in which a lamina densa width
between 1,000 to 2,000 A was considered abnormal [23, 24].
The GBM thickness is known to increase with age from a
normal mean width of 1100 A in "young children" to a mean
value of 2700 A in "older children and adults" [27]. However, a
young age cannot be invoked to explain the attenuated GBM
thickness in the 17 affected children since their mean age (9.3
years) was not different from that of the entire sample popula-
tion (9.8 years). While some authors consider this finding
specific for benign familial hematuria [23, 241, it is also included
in the broad spectrum of GBM abnormalities that have been
described in association with Alport syndrome [22, 25, 26, 281.
Table 3. Isolated hematuria: Renal biopsy results by clinical
categories
IMH and
IMHab Fa
N % N %
IMH and
GHb
N %
a IMH vs. IMH and F: X2 = 4.8, P < 0.03.
IMH vs. IMH and GH: X2 = 7.8,P < 0.005.
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In fact, some investigators consider thinning of the GBM a
forme fruste of Alport syndome [25]. Therefore, since attenua-
tion of the GBM has been described in all forms of familial
hematuria, its presence does not enable one to discriminate
between benign familial hematuria and progressive hereditary
nephritis [25, 29]. The family history and clinical course of other
affected family members appeared to be the only reliable
prognostic indicators of an individual patient's outcome [291. In
our series, none of the 17 children with thinning of the GBM had
sensorineural hearing loss. Moreover, there was not an in-
creased frequency of a positive family history of hematuria
among these children compared to the total sample population.
The prognosis for these children will remain unknown until a
large cohort is prospectively followed. Similarly, the clinical
outcome for the children with vascular C3 immunofluorescence
staining is unclear. This lesion has been documented in a recent
clinico-pathologic study of isolated proteinuria in school age
children [30] and in children with IgA nephropathy [18]. It has
never been reported in children with isolated hematuria. Our
patients with this lesion had no clinical or laboratory findings
that distinguished them from the other children with isolated
hematuria. This histologic abnormality cannot presently be
considered a definite disease entity with long-term implications.
When the population of children with hematuria was divided
into distinct clinical categories, characteristics were identified
which were associated with an increased frequency of abnormal
renal histology. These features were selected because they
were likely to correlate with the occurrence of renal histopa-
thology and are readily available to the primary care physician
prior to referral for renal biopsy. Among the 42 children who
had only IMH, 40% of their biopsy specimens were not entirely
normal; however, 88% of the abnormalities noted were either
thinning of the GBM or vascular C3 staining, lesions of un-
known, but doubtful clinical significance (Table 4). The benign
renal biopsy findings among the children with isolated micro-
scopic hematuria agree with those of Vehaskari et al [2], in
which one possible case of Alport syndrome and two cases of
IgA nephropathy were detected among 28 children with IMH.
The presence of a family history of hematuria in a first degree
relative increased the yield of an abnormality from 40 to 64%,
and the presence of gross hematuria further enhanced the
likelihood of an abnormal renal histology to 79% (Table 3).
Moreover, clinically relevant entities, namely Alport syn-
drome, IgA nephropathy, comprised 58% (15 of 26) of the
abnormal biopsy results in these latter two clinical categories
(Table 4). The combination of both risk factors, namely a
positive family history and the occurrence of gross hematuria,
was uniformly associated with an abnormal renal biopsy speci-
men. No other factor examined, including sex, age, or duration
of hematuria, had any predictive value for abnormal histology.
Knowledge of these clinical features should enable the practi-
tioner to predict the likelihood of obtaining an abnormal renal
biopsy result in a child with hematuria.
In conclusion, based on these findings and our interpretation
of the biopsy results, we would make the following recommen-
dations with regard to a child who has had isolated hematuria
lasting longer than 6 months. If there is a positive family history
of hematuria in a first degree relative or the patient has had at
least one episode of gross hematuria, then a renal biopsy is
indicated. According to our findings, nearly 75% of such biopsy
specimens will be abnormal and clinically important diagnoses,
namely IgA nephropathy and Alport syndrome, will be made in
the majority (60%) of cases. However, for the child who has
only IMH, a renal biopsy is not a useful diagnostic procedure
since it can nearly always be expected to reveal either normal
morphology or nonspecific alterations of unknown clinical
relevance. Until the implications of GBM thinning and vascular
C3 staining become clarified in multicenter prospective studies,
the risk of routinely subjecting such children to a renal biopsy
may outweigh any gain to be accrued from the early knowledge
of a histological abnormality. This conclusion is supported by
our followup information that failed to reveal any new urinary
abnormality or deterioration in renal function among these
children. Careful followup examinations for proteinuria, hyper-
tension or decrease in GFR are warranted and any new finding
should prompt re-evaluation of the patient and the need for a
renal biopsy.
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